Davide Schiffer
Vercelli, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Chondroitin Sulphate Proteoglycans in the Tumour Microenvironment.
Journal: Advances in experimental medicine and biology
Published: August 27, 2020
Chondroitin Sulphate Proteoglycan 4 (NG2/CSPG4) Localization in Low- and High-Grade Gliomas.
Journal: Cells
Published: February 21, 2020
Validation of Thiosemicarbazone Compounds as P-Glycoprotein Inhibitors in Human Primary Brain-Blood Barrier and Glioblastoma Stem Cells.
Journal: Molecular pharmaceutics
Published: July 03, 2019
SEL1L plays a major role in human malignant gliomas.
Journal: The journal of pathology. Clinical research
Published: March 04, 2019
The Significance of Chondroitin Sulfate Proteoglycan 4 (CSPG4) in Human Gliomas.
Journal: International journal of molecular sciences
Published: July 24, 2018
Carbonic Anhydrase XII Inhibitors Overcome P-Glycoprotein-Mediated Resistance to Temozolomide in Glioblastoma.
Journal: Molecular cancer therapeutics
Published: May 16, 2018
Glioblastoma niches: from the concept to the phenotypical reality.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: January 20, 2018
Solid Lipid Nanoparticles Carrying Temozolomide for Melanoma Treatment. Preliminary In Vitro and In Vivo Studies.
Journal: International journal of molecular sciences
Published: December 20, 2017
Comparison of Allogeneic and Syngeneic Rat Glioma Models by Using MRI and Histopathologic Evaluation.
Journal: Comparative medicine
Published: April 07, 2017
Last Updated: 09/26/2026